Keyphrases
Effector Cells
100%
Genetic Engineering
100%
Tumor Microenvironment
100%
Chemokine Receptor
100%
Tumor Site
100%
Antitumor T Cells
50%
Response Rate
50%
Effector T Cells
50%
Cancer Immune Therapy
50%
Metastatic Melanoma
50%
Immune Suppressive Cells
50%
Cell Subsets
50%
Immune Therapy
50%
Immune Cells
50%
Personalized Medicine
50%
Adoptive Cell Transfer
50%
Infiltration
50%
Metastatic Disease
50%
Engineered T Cells
50%
Chemokines
50%
Inhibitory Receptors
50%
Physical Exercise
50%
Phase III Clinical Trial
50%
Chemical Barrier
50%
In Vitro Tumor Models
50%
Antitumor
50%
Cancer Diagnosis
50%
Physical Barrier
50%
Microenvironment
50%
Tumor
50%
Hypoxia
50%
Vascularization
50%
Medicine and Dentistry
Neoplasm
100%
Chemokine Receptor
100%
T Cell
100%
Genetic Engineering
28%
Effector Cell
28%
Immunotherapy
28%
Immunity
28%
Tumor Microenvironment
28%
Malignant Neoplasm
28%
Receptor
14%
Metastatic Carcinoma
14%
Vascularity
14%
Immunocompetent Cell
14%
Personalized Medicine
14%
Metastatic Melanoma
14%
Upregulation
14%
Clinical Trial
14%
Transfer Cell
14%
Hypoxia
14%
Cancer Diagnosis
14%
Chemokine
14%
T Cell Receptor
14%